Rare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Covid-19 vaccines: scientists report to journal

Adenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled out from the market, contain a component that can trigger blood clots in genetically susceptible individuals, scientists reported Wednesday in a letter to the New England Journal of Medicine.

Livemint
Published16 May 2024, 01:56 PM IST
Researchers investigate the autoimmune reaction linked to rare blood clots caused by Johnson & Johnson and AstraZeneca Covid-19 vaccines, aiming to improve future vaccine safety.
Researchers investigate the autoimmune reaction linked to rare blood clots caused by Johnson & Johnson and AstraZeneca Covid-19 vaccines, aiming to improve future vaccine safety.

Rare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Plc’s Covid-19 vaccines were caused by an autoimmune reaction that some people are predisposed to, researchers have found. This discovery is expected to influence the development of future vaccines, Bloomberg reported.

Adenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the market, contain a component that can trigger blood clots in genetically susceptible individuals, scientists reported Wednesday in a letter to the New England Journal of Medicine. Researchers are now aiming to identify the specific component and attempt to remove it through genetic engineering, the report said.

“It’s not known how many people may be susceptible to the complication,” said Tom Gordon, head of immunology at Flinders University in South Australia, whose molecular investigation led to the finding. The immune reaction linked to the shot is “a new disease,” he stated in an interview. “I think as haematologists and intensive care specialists become more familiar with these conditions, more cases will be described," the scientists Bloomberg.

Out of more than 18 million people who received the single-dose J&J vaccine, 60 cases of the clotting disorder were reported, resulting in nine deaths, according to the Yale School of Medicine, Bloomberg reported.

A small number of clot-related deaths linked to the AstraZeneca vaccine led to its withdrawal or restriction in Denmark, Norway, and other countries in 2021. The complication occurred in about 2-3 people per 100,000 vaccinated with the AstraZeneca shot under age 60 in Australia, where it hasn’t been available since March 2023. The European Commission withdrew the marketing authorization for the vaccine in March 2024, the Bloomberg report said.

“AstraZeneca welcomes any further examination of the possible underlying mechanism of thrombosis with thrombocytopenia syndrome (TTS), given that, despite extensive investigation, we do not yet understand the mechanism that can in very rare cases be a trigger for TTS,” a spokesperson for the company said, as per the report.

J&J also expressed support for research that helps guide the development of safe and effective vaccines. “More data are needed to fully understand potential factors that may be associated with this rare event, including its potential relationship with adeno- and other viruses, to draw appropriate conclusions about the underlying pathogenesis,” the company said in an email.

Both vaccines played a crucial role in early pandemic vaccine programmes. An analysis found the AstraZeneca vaccine saved an estimated 6.3 million lives in 2021.

The mRNA vaccines made by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. were later found to be more effective at protecting against Covid and have been updated to tackle more recent virus variants.

(With Inputs from Bloomberg)

Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:16 May 2024, 01:56 PM IST
Business NewsNewsWorldRare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Covid-19 vaccines: scientists report to journal

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Indian Oil Corporation share price

    138.95
    03:29 PM | 4 NOV 2024
    -6.05 (-4.17%)

    Tata Steel share price

    147.00
    03:29 PM | 4 NOV 2024
    -2.7 (-1.8%)

    Reliance Industries share price

    1,298.90
    03:29 PM | 4 NOV 2024
    -40.2 (-3%)

    Tata Motors share price

    824.20
    03:29 PM | 4 NOV 2024
    -19.4 (-2.3%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    City Union Bank share price

    178.10
    03:29 PM | 4 NOV 2024
    0.25 (0.14%)

    Federal Bank share price

    203.50
    03:29 PM | 4 NOV 2024
    -0.75 (-0.37%)

    Jubilant Pharmova share price

    1,243.00
    03:29 PM | 4 NOV 2024
    -21 (-1.66%)

    UTI Asset Management Company share price

    1,326.85
    03:29 PM | 4 NOV 2024
    -33.4 (-2.46%)
    More from 52 Week High

    Poly Medicure share price

    2,864.00
    03:29 PM | 4 NOV 2024
    -298.7 (-9.44%)

    Vodafone Idea share price

    7.87
    03:29 PM | 4 NOV 2024
    -0.58 (-6.86%)

    Chennai Petroleum Corporation share price

    615.10
    03:29 PM | 4 NOV 2024
    -40.45 (-6.17%)

    Angel Broking share price

    2,889.25
    03:29 PM | 4 NOV 2024
    -181.65 (-5.92%)
    More from Top Losers

    Fine Organic Industries share price

    5,123.00
    03:29 PM | 4 NOV 2024
    280.9 (5.8%)

    Firstsource Solutions share price

    355.30
    03:29 PM | 4 NOV 2024
    15 (4.41%)

    Rainbow Childrens Medicare share price

    1,615.00
    03:29 PM | 4 NOV 2024
    65.4 (4.22%)

    Gillette India share price

    10,323.35
    03:29 PM | 4 NOV 2024
    361.55 (3.63%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      80,415.000.00
      Chennai
      80,421.000.00
      Delhi
      80,573.000.00
      Kolkata
      80,425.000.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.92/L0.00
      Chennai
      101.03/L0.23
      Kolkata
      104.95/L0.00
      New Delhi
      94.77/L0.00

      Popular in News

        HomeMarketsPremiumInstant LoanMint Shorts